The University of Puerto Rico, School of Medicine, Pediatric HIV/AIDS Research Program has the mission to provide excellent interdisciplinary health care services and clinical research to children and adolescents infected or affected by HIV. This program is the referral center for pediatric HIV care for Puerto Rico and the Caribbean Basin and has contributed significantly to the health of HIV affected children and to the reduction of perinatal transmission in the Island. After more than a decade of clinical research, this unit has recruited over 550 individuals to clinical trials. Part of the Pediatric AIDS Clinical Trials Group since 1992, this unit has maintained excellent performance, in addition to outstanding recruitment and retention, and compliance with all regulatory requirements, contributing to the PACTG research agenda. During the last four years we have recruited 279 subjects to PACTG clinical trials, including perinatal, primary therapy, immune based therapy, and complications of HIV protocols; maintaining accrual significantly above the group median. Our unit's research team has contributed to the PACTG by participating as scientific and support committee members, protocol team members, and protocol chair and co-chair. One of our Community Advisory Board members, participates in the Community Constituency Group, and has significantly contributed to the achievements of this group. The Unit's personnel have the expertise to perform and conduct clinical trials, maintaining compliance with all local and federal regulations. The Unit is actively recruiting patients to PACTG clinical trials and will continue to enroll children, adolescent and pregnant women, maintaining high accrual, retention and performance. The Unit's main goal is to continue the collaborative work with the PACTG to accomplish the scientific research agenda.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-PSS-A (J1))
Program Officer
Germuga, Donna E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Puerto Rico Med Sciences
Schools of Medicine
San Juan
United States
Zip Code
Melendez, Margarita; Blanco, Raul; Delgado, Wilfredo et al. (2006) Lack of evidence for in vivo transformation of zidovudine triphosphate to stavudine triphosphate in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 50:835-40
Hillyer, George V; Febo, Irma; Diaz, Clemente (2002) The rapid diagnosis of HIV-1 infection in mothers in Puerto Rico: a crucial testing strategy for maximal reduction of perinatal transmission. P R Health Sci J 21:133-5
Rodriguez, J F; Rodriguez, J L; Escobales, N et al. (2000) Total plasma homocysteine concentrations in Puerto Rican patients with presumptive atherosclerotic coronary disease. P R Health Sci J 19:253-8
Rodriguez, J F; Rodriguez, J L; Santana, J et al. (2000) Simultaneous quantitation of intracellular zidovudine and lamivudine triphosphates in human immunodeficiency virus-infected individuals. Antimicrob Agents Chemother 44:3097-100
Zorrilla, C D (2000) Antiretroviral combination therapy in HIV-1 infected women and men: are their responses different? Int J Fertil Womens Med 45:195-9
Rodriguez Orengo, J F; Santana, J; Febo, I et al. (2000) Intracellular studies of the nucleoside reverse transcriptase inhibitor active metabolites: a review. P R Health Sci J 19:19-27
Font, E; Rosario, O; Santana, J et al. (1999) Determination of zidovudine triphosphate intracellular concentrations in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals by tandem mass spectrometry. Antimicrob Agents Chemother 43:2964-8
Rodriguez, J F; Cordero, J; Chantry, C et al. (1998) Plasma glutathione concentrations in children infected with human immunodeficiency virus. Pediatr Infect Dis J 17:236-41
Chantry, C J; Cooper, E R; Pelton, S I et al. (1995) Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatr Infect Dis J 14:382-7